New therapy for central retinal vein occlusion: Are intravitreal steroids a possible answer?

Archives of Ophthalmology

Volumn 123, Issue 2, 2005, Pages 259-261

  Blumenkranz, Mark S ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE DERIVATIVE; FIBRINOLYTIC AGENT; PLASMINOGEN ACTIVATOR; STEROID;

CANNULATION; CENTRAL RETINA VEIN OCCLUSION; CLINICAL TRIAL; DIABETIC RETINOPATHY; DRUG EFFECT; DRUG EFFICACY; HUMAN; INCIDENCE; LASER COAGULATION; LASER SURGERY; NEOVASCULAR GLAUCOMA; OPTICAL COHERENCE TOMOGRAPHY; ORBIT CYST; PRIORITY JOURNAL; RETINA EDEMA; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA EDEMA; SHORT SURVEY; THROMBOSIS; UNITED STATES; VISUAL ACUITY; VISUAL IMPAIRMENT;

CLINICAL TRIALS; GLUCOCORTICOIDS; HUMANS; RETINAL VEIN OCCLUSION; VITREOUS BODY;

EID: 13244277956     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.123.2.259     Document Type: Short Survey

References (24)

1. Klein R, Klein BEK, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2000; 98:133-143.
2. US Census Bureau. Available at: http://eire.census.gov/popest/data.
3. The Central Vein Occlusion Study Group. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion: the Central Vein Occlusion Study Group N Report. Ophthalmology. 1995;102:1434-1444.
4. The Central Vein Occlusion Study Group. Evaluation of grid photocoagulation for macular edema in central vein occlusion: the Central Vein Occlusion Study Group M Report. Ophthalmology. 1995; 102:1425-1433.
5. Glacet-Bernard A, Zourdani A, Milhoub M, Maraqua N, Coscas G, Soubrane G. Effect of isovolemic hemodilution in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2001;239:909-914.
6. McAllister IL, Douglas JP, Constable IJ, Yu D-Y. Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: evaluation of the complications and their risk factors. Am J Ophthalmol. 1998;126:219-229.
7. Lam HD, Blumenkranz MS. Treatment of central retinal vein occlusion by vitrectomy with lysis of vitreopapillary adhesions, subretinal peripapillary TPA injection and photocoagulation. Am J Ophthalmol. 2002;134:609-611.
8. Paques M, Vallee JN, Herbreteau D, et al. Super-selective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion. Br J Ophthalmol. 2000;84:1387-1391.
9. Opremcak EM, Bruce RA, Lomeo MD, Ridenour CD, Letson AD, Rehmar AJ. Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases. Retina. 2001;21:408-415.
10. Weiss JN. Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein. Am J Ophthalmol. 1998;126:142-144.
11. Shaikh S, Blumenkranz MS. Transient improvement in visual acuity and macular edema in central retinal vein occlusion accompanied by inflammatory features after pulse steroid and antiinflammatory therapy. Retina. 2001;21:176-178.
12. Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol. 2002;86:247-248.
13. Ip MS, Kumar KS. Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion. Arch Ophthalmol. 2002; 120:1217-1219.
14. Ip M, Kahana A, Altaweel M. Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study. Semin Ophthalmol. 2003;18:67-73.
15. Park C, Jaffe G, Fekrat S. Intravitreal triamcinolone acetonide in eyes with cystoid macula edema associated with central retinal vein occlusion Am J Ophthalmol. 2003;136:419-425.
16. Jonas JB, Kreissig I, Degenring R. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2002;240:782-783.
17. Bynoe L, Weiss J. Retinal endovascular surgery and intravitreal triamcinolone acetonide for central vein occlusion in young adults Am J Ophthalmol. 2003;135:382-384.
18. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology. 2002;109:920-927.
19. Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc. 1981;79:371-422.
20. The Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol. 1997;115:486-491.
21. McCuen BW, Bessler M, Tano Y, Chandler D, Machemer R. The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol. 1981;91:785-788.
22. Danis RP, Ciulla TA, Pratt LM, Anliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina. 2000; 20:244-250.
23. Benz MS, Murray TG, Dubovy SR, Katz RS, Eifrig CW. Endophthalmitis caused by mycobacterium chelonae abscessus after intravitreal injection of triamcinolone. Arch Ophthalmol. 2003;121:271-273.
24. Moshfeghi DM, Kaiser PK, Scott IU, et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol. 2003; 136:791-796.